The Food and Drug Administration is seeking comment on its regulation of pet foods marketed with environmental claims and has scheduled a virtual listening session on the topic for Oct. 18.
The FDA said it is currently reviewing its policy manual, “Regulating Pet Foods with Drug Claims,” and is seeking feedback on how to update it “to reflect changing scientific knowledge and promote innovation policy in animal feed”.
Critics of the FDA’s process for reviewing food ingredients, including the hemp industry and several Capitol Hill lawmakers, say the process is too long and cumbersome. FDA Commissioner Robert Califf promised during a Senate Appropriations Committee hearing last month that the agency would review the policy manual.
The session will focus on regulating foods “with certain types of claims,” the FDA said, including those involving greenhouse gas reductions, growth promotion, food efficiency, as well as claims regarding effects on the animal microbiome.
The manual states that “based on the claims made for these items, their intended uses may bring them within the definition of a drug under section 201(g). In such cases, the articles may, in law, be both a food and a drug. »
Stakeholders interested in attending the virtual listening session must register by noon on October 11. Comments are also accepted on the FDA’s online filing.
For more news, visit www.Agri-Pulse.com.